Clindamycin-Loaded Nanosized Calcium Phosphates Powders as a Carrier of Active Substances.
Dagmara SłotaKarina PiętakWioletta FlorkiewiczJosef JampilekAgnieszka TomalaMateusz M UrbaniakAgata TomaszewskaKarolina RudnickaAgnieszka Sobczak-KupiecPublished in: Nanomaterials (Basel, Switzerland) (2023)
Bioactive calcium phosphate ceramics (CaPs) are one of the building components of the inorganic part of bones. Synthetic CaPs are frequently used as materials for filling bone defects in the form of pastes or composites; however, their porous structure allows modification with active substances and, thus, subsequent use as a drug carrier for the controlled release of active substances. In this study, four different ceramic powders were compared: commercial hydroxyapatite (HA), TCP, brushite, as well as HA obtained by wet precipitation methods. The ceramic powders were subjected to physicochemical analysis, including FTIR, XRD, and determination of Ca/P molar ratio or porosity. These techniques confirmed that the materials were phase-pure, and the molar ratios of calcium and phosphorus elements were in accordance with the literature. This confirmed the validity of the selected synthesis methods. CaPs were then modified with the antibiotic clindamycin. Drug release was determined on HPLC, and antimicrobial properties were tested against Staphylococcus aureus . The specific surface area of the ceramic has been demonstrated to be a factor in drug release efficiency.
Keyphrases
- drug release
- drug delivery
- staphylococcus aureus
- drinking water
- ms ms
- cancer therapy
- systematic review
- solid phase extraction
- simultaneous determination
- tissue engineering
- biofilm formation
- drug induced
- tandem mass spectrometry
- molecularly imprinted
- adverse drug
- cystic fibrosis
- soft tissue
- electronic health record
- water soluble